Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
International Journal of Cancer|August 6, 2019
Optimizing T-cell receptor avidity with somatic hypermutationDavid Bassan, Yosi Meir Gozlan, Adi Sharbi-Yunger, et al.International Journal of Cancer|February 18, 2022
On the development of a neoantigen vaccine for the prevention of Lynch SyndromeAdam Solomon, Zoya Alteber, David Bassan, et al.Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|September 7, 2013
[Sensitization and oral challenge with ovoalbumin in an animal model of food allergy]Miguel Ngel Vinuesa, Norberto David Bassan, Soledad Chaparro, et al.European Journal of Immunology|April 9, 2021
Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutationDavid Bassan, Yosi Meir Gozlan, Adi Sharbi-Yunger, et al.Pigment Cell & Melanoma Research|April 18, 2018
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanomaMichal Alon, Rafi Emmanuel, Nouar Qutob, et al.International Journal of Cancer|August 15, 2018
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalAdi Sharbi-Yunger, Mareike Grees, Gal Cafri, et al.Journal for Immunotherapy of Cancer|December 14, 2023
HER2 and HLA-A*02 dual CAR-T cells utilize LOH in a NOT logic gate to address on-target off-tumor toxicityDavid Bassan, Leehee Weinberger, Jason Yi, et al.Cell|December 16, 2025
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasionYoav Chemla, Orit Itzhaki, Stav Melamed, et al.Pageof 1